A grant by the Alzheimer's Drug Discovery Foundation (ADDF) will support research into the role of mitochondria in Alzheimer's disease. The award of $205,260 will go to CohBar Inc., of Pasadena, Calif., which is developing a mitochondrial peptide designed to protect neurons from dying by improving mitochondrial function, reducing inflammation, increasing insulin sensitivity and decreasing oxidative stress.